biorepository

Tempus and Rush will work together to rapidly collect and analyze important biospecimens to fuel cancer research. 

The Human Cancer Models Initiative aims to create about 1,000 cancer cell lines that scientists can use to study tumor progression, drug resistance, and more.

NEW YORK (GenomeWeb) – Moffitt Cancer Center and M2Gen today said they have been awarded a seven-year, $7.3 million contract from the National Heart, Lung, and Blood Institute to coordinate a central laboratory and biorepository for research into myelodysplastic syndromes.

NEW YORK (GenomeWeb) – Japanese stem cell products company Reprocell said today that it has purchased 3D cell culture firm Reinnervate and US genomics services firm BioServe.

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research recently announced a $7.7 million contract extension from the National Institute for Neurological Disorders and Stroke to maintain the institute's biobank.

NEW YORK (GenomeWeb News) – The China National Genebank today announced a deal under which BioStorage Technologies will provide biorepository expertise, technology, and processes to support the development of "one of the world's largest genomic biobanks."

NEW YORK (GenomeWeb News) – The National Institutes of Health has pumped $17 million into new grants to fund a consortium of genomics research centers and projects in Africa, with the goal of advancing research, training new investigators, and ramping up genomics capabilities and infrastructure a

NEW YORK (GenomeWeb News) – An $11.8 million renovation of RUCDR Infinite Biologics, a university-based biorepository, has been completed, creating a new Genomics Technology Center.

NEW YORK (GenomeWeb News) – The National Institute of Diabetes, Digestive, and Kidney Diseases has established a biosample and data repository using samples from many of the clinical studies and trials it has funded, and it now

NEW YORK (GenomeWeb News) – SeraCare Life Sciences announced late on Thursday a reorganization of its business after selling off certain segments.

Pages

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.